img

Global Dog Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dog Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
The global Dog Vaccines market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Dog Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Dog Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Dog Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Dog Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Dog Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
By Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application
Below 6 Months
Above Months
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Dog Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dog Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Dog Vaccines Definition
1.2 Market by Type
1.2.1 Global Dog Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market Segment by Application
1.3.1 Global Dog Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Dog Vaccines Sales
2.1 Global Dog Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Dog Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Dog Vaccines Revenue by Region
2.3.1 Global Dog Vaccines Revenue by Region (2018-2024)
2.3.2 Global Dog Vaccines Revenue by Region (2024-2034)
2.4 Global Dog Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Dog Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Dog Vaccines Sales Quantity by Region
2.6.1 Global Dog Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Dog Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Dog Vaccines Sales Quantity by Manufacturers
3.1.1 Global Dog Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Dog Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Dog Vaccines Sales in 2022
3.2 Global Dog Vaccines Revenue by Manufacturers
3.2.1 Global Dog Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Dog Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dog Vaccines Revenue in 2022
3.3 Global Dog Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Dog Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dog Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Dog Vaccines Sales Quantity by Type
4.1.1 Global Dog Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Dog Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Dog Vaccines Revenue by Type
4.2.1 Global Dog Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Dog Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Dog Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Dog Vaccines Price by Type
4.3.1 Global Dog Vaccines Price by Type (2018-2024)
4.3.2 Global Dog Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Dog Vaccines Sales Quantity by Application
5.1.1 Global Dog Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Dog Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Dog Vaccines Revenue by Application
5.2.1 Global Dog Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Dog Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Dog Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Dog Vaccines Price by Application
5.3.1 Global Dog Vaccines Price by Application (2018-2024)
5.3.2 Global Dog Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Dog Vaccines Sales by Company
6.1.1 North America Dog Vaccines Revenue by Company (2018-2024)
6.1.2 North America Dog Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Dog Vaccines Market Size by Type
6.2.1 North America Dog Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Dog Vaccines Revenue by Type (2018-2034)
6.3 North America Dog Vaccines Market Size by Application
6.3.1 North America Dog Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Dog Vaccines Revenue by Application (2018-2034)
6.4 North America Dog Vaccines Market Size by Country
6.4.1 North America Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Dog Vaccines Revenue by Country (2018-2034)
6.4.3 North America Dog Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Dog Vaccines Sales by Company
7.1.1 Europe Dog Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Dog Vaccines Revenue by Company (2018-2024)
7.2 Europe Dog Vaccines Market Size by Type
7.2.1 Europe Dog Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Dog Vaccines Revenue by Type (2018-2034)
7.3 Europe Dog Vaccines Market Size by Application
7.3.1 Europe Dog Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Dog Vaccines Revenue by Application (2018-2034)
7.4 Europe Dog Vaccines Market Size by Country
7.4.1 Europe Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Dog Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Dog Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Dog Vaccines Sales by Company
8.1.1 China Dog Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Dog Vaccines Revenue by Company (2018-2024)
8.2 China Dog Vaccines Market Size by Type
8.2.1 China Dog Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Dog Vaccines Revenue by Type (2018-2034)
8.3 China Dog Vaccines Market Size by Application
8.3.1 China Dog Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Dog Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Dog Vaccines Sales by Company
9.1.1 APAC Dog Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Dog Vaccines Revenue by Company (2018-2024)
9.2 APAC Dog Vaccines Market Size by Type
9.2.1 APAC Dog Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Dog Vaccines Revenue by Type (2018-2034)
9.3 APAC Dog Vaccines Market Size by Application
9.3.1 APAC Dog Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Dog Vaccines Revenue by Application (2018-2034)
9.4 APAC Dog Vaccines Market Size by Region
9.4.1 APAC Dog Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Dog Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Dog Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dog Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Dog Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Dog Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Dog Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Bayer Healthcare Dog Vaccines Products and Services
11.1.5 Bayer Healthcare Dog Vaccines SWOT Analysis
11.1.6 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Vetoquinol S.A Dog Vaccines Products and Services
11.2.5 Vetoquinol S.A Dog Vaccines SWOT Analysis
11.2.6 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Dog Vaccines Products and Services
11.3.5 Boehringer Ingelheim Dog Vaccines SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Ceva Dog Vaccines Products and Services
11.4.5 Ceva Dog Vaccines SWOT Analysis
11.4.6 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Eli Lilly Dog Vaccines Products and Services
11.5.5 Eli Lilly Dog Vaccines SWOT Analysis
11.5.6 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Company Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Heska Co. Dog Vaccines Products and Services
11.6.5 Heska Co. Dog Vaccines SWOT Analysis
11.6.6 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Merck Animal Health Dog Vaccines Products and Services
11.7.5 Merck Animal Health Dog Vaccines SWOT Analysis
11.7.6 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Merial (Sanofi) Dog Vaccines Products and Services
11.8.5 Merial (Sanofi) Dog Vaccines SWOT Analysis
11.8.6 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Overview
11.9.3 Virbac Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Virbac Dog Vaccines Products and Services
11.9.5 Virbac Dog Vaccines SWOT Analysis
11.9.6 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Dog Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Zoetis (Pfizer) Dog Vaccines Products and Services
11.10.5 Zoetis (Pfizer) Dog Vaccines SWOT Analysis
11.10.6 Zoetis (Pfizer) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Dog Vaccines Value Chain Analysis
12.2 Dog Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dog Vaccines Production Mode & Process
12.4 Dog Vaccines Sales and Marketing
12.4.1 Dog Vaccines Sales Channels
12.4.2 Dog Vaccines Distributors
12.5 Dog Vaccines Customers
13 Market Dynamics
13.1 Dog Vaccines Industry Trends
13.2 Dog Vaccines Market Drivers
13.3 Dog Vaccines Market Challenges
13.4 Dog Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dog Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Dog Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Dog Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Dog Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Dog Vaccines Revenue Market Share by Region (2018-2024)
Table 13. Global Dog Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 14. Global Dog Vaccines Revenue Market Share by Region (2024-2034)
Table 15. Global Dog Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Doses)
Table 16. Global Dog Vaccines Sales by Region (2018-2024) & (K Doses)
Table 17. Global Dog Vaccines Sales Market Share by Region (2018-2024)
Table 18. Global Dog Vaccines Sales by Region (2024-2034) & (K Doses)
Table 19. Global Dog Vaccines Sales Market Share by Region (2024-2034)
Table 20. Global Dog Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Doses)
Table 21. Global Dog Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 22. Global Dog Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Dog Vaccines Revenue Share by Manufacturers (2018-2024)
Table 24. Global Dog Vaccines Price by Manufacturers 2018-2024 (USD/Dose)
Table 25. Global Key Players of Dog Vaccines, Industry Ranking, 2021 VS 2022
Table 26. Global Dog Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Dog Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Vaccines as of 2022)
Table 28. Global Key Manufacturers of Dog Vaccines, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Dog Vaccines, Product Offered and Application
Table 30. Global Key Manufacturers of Dog Vaccines, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 33. Global Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 34. Global Dog Vaccines Sales Quantity Share by Type (2018-2024)
Table 35. Global Dog Vaccines Sales Quantity Share by Type (2024-2034)
Table 36. Global Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Dog Vaccines Revenue Share by Type (2018-2024)
Table 39. Global Dog Vaccines Revenue Share by Type (2024-2034)
Table 40. Dog Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 41. Global Dog Vaccines Price Forecast by Type (2024-2034) & (USD/Dose)
Table 42. Global Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 43. Global Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 44. Global Dog Vaccines Sales Quantity Share by Application (2018-2024)
Table 45. Global Dog Vaccines Sales Quantity Share by Application (2024-2034)
Table 46. Global Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Dog Vaccines Revenue Share by Application (2018-2024)
Table 49. Global Dog Vaccines Revenue Share by Application (2024-2034)
Table 50. Dog Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 51. Global Dog Vaccines Price Forecast by Application (2024-2034) & (USD/Dose)
Table 52. North America Dog Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 53. North America Dog Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 54. North America Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 55. North America Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 56. North America Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 57. North America Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 58. North America Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 59. North America Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 60. North America Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 61. North America Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 62. North America Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 63. North America Dog Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 64. North America Dog Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 65. North America Dog Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 66. North America Dog Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 67. Europe Dog Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 68. Europe Dog Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 69. Europe Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 70. Europe Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 71. Europe Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 72. Europe Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 73. Europe Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 74. Europe Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 75. Europe Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 76. Europe Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 77. Europe Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 78. Europe Dog Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 79. Europe Dog Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 80. Europe Dog Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 81. Europe Dog Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 82. China Dog Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 83. China Dog Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 84. China Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 85. China Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 86. China Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 87. China Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 88. China Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 89. China Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 90. China Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 91. China Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 92. APAC Dog Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 93. APAC Dog Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 94. APAC Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 95. APAC Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 96. APAC Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. APAC Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 98. APAC Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 99. APAC Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 100. APAC Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. APAC Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 102. APAC Dog Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. APAC Dog Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 104. APAC Dog Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 105. APAC Dog Vaccines Sales Quantity by Region (2018-2024) & (K Doses)
Table 106. APAC Dog Vaccines Sales Quantity by Region (2024-2034) & (K Doses)
Table 107. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 108. Middle East, Africa and Latin America Dog Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 110. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 111. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Dog Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 114. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 115. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Dog Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Dog Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 118. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 119. Middle East, Africa and Latin America Dog Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 120. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 121. Middle East, Africa and Latin America Dog Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 122. Bayer Healthcare Company Information
Table 123. Bayer Healthcare Description and Overview
Table 124. Bayer Healthcare Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 125. Bayer Healthcare Dog Vaccines Product and Services
Table 126. Bayer Healthcare Dog Vaccines SWOT Analysis
Table 127. Bayer Healthcare Recent Developments
Table 128. Vetoquinol S.A Company Information
Table 129. Vetoquinol S.A Description and Overview
Table 130. Vetoquinol S.A Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 131. Vetoquinol S.A Dog Vaccines Product and Services
Table 132. Vetoquinol S.A Dog Vaccines SWOT Analysis
Table 133. Vetoquinol S.A Recent Developments
Table 134. Boehringer Ingelheim Company Information
Table 135. Boehringer Ingelheim Description and Overview
Table 136. Boehringer Ingelheim Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 137. Boehringer Ingelheim Dog Vaccines Product and Services
Table 138. Boehringer Ingelheim Dog Vaccines SWOT Analysis
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Ceva Company Information
Table 141. Ceva Description and Overview
Table 142. Ceva Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 143. Ceva Dog Vaccines Product and Services
Table 144. Ceva Dog Vaccines SWOT Analysis
Table 145. Ceva Recent Developments
Table 146. Eli Lilly Company Information
Table 147. Eli Lilly Description and Overview
Table 148. Eli Lilly Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 149. Eli Lilly Dog Vaccines Product and Services
Table 150. Eli Lilly Dog Vaccines SWOT Analysis
Table 151. Eli Lilly Recent Developments
Table 152. Heska Co. Company Information
Table 153. Heska Co. Description and Overview
Table 154. Heska Co. Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 155. Heska Co. Dog Vaccines Product and Services
Table 156. Heska Co. Dog Vaccines SWOT Analysis
Table 157. Heska Co. Recent Developments
Table 158. Merck Animal Health Company Information
Table 159. Merck Animal Health Description and Overview
Table 160. Merck Animal Health Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 161. Merck Animal Health Dog Vaccines Product and Services
Table 162. Merck Animal Health Dog Vaccines SWOT Analysis
Table 163. Merck Animal Health Recent Developments
Table 164. Merial (Sanofi) Company Information
Table 165. Merial (Sanofi) Description and Overview
Table 166. Merial (Sanofi) Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 167. Merial (Sanofi) Dog Vaccines Product and Services
Table 168. Merial (Sanofi) Dog Vaccines SWOT Analysis
Table 169. Merial (Sanofi) Recent Developments
Table 170. Virbac Company Information
Table 171. Virbac Description and Overview
Table 172. Virbac Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 173. Virbac Dog Vaccines Product and Services
Table 174. Virbac Dog Vaccines SWOT Analysis
Table 175. Virbac Recent Developments
Table 176. Zoetis (Pfizer) Company Information
Table 177. Zoetis (Pfizer) Description and Overview
Table 178. Zoetis (Pfizer) Dog Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 179. Zoetis (Pfizer) Dog Vaccines Product and Services
Table 180. Zoetis (Pfizer) Dog Vaccines SWOT Analysis
Table 181. Zoetis (Pfizer) Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Dog Vaccines Distributors List
Table 185. Dog Vaccines Customers List
Table 186. Dog Vaccines Market Trends
Table 187. Dog Vaccines Market Drivers
Table 188. Dog Vaccines Market Challenges
Table 189. Dog Vaccines Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Vaccines Product Picture
Figure 2. Global Dog Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Dog Vaccines Market Share by Type in 2022 & 2034
Figure 4. Attenuated Live Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Inactivated Vaccines Product Picture
Figure 7. Subunit Vaccines Product Picture
Figure 8. Toxoid Vaccines Product Picture
Figure 9. DNA Vaccines Product Picture
Figure 10. Recombinant Vaccines Product Picture
Figure 11. Global Dog Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Dog Vaccines Market Share by Application in 2022 & 2034
Figure 13. Below 6 Months
Figure 14. Above Months
Figure 15. Dog Vaccines Report Years Considered
Figure 16. Global Dog Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Dog Vaccines Revenue 2018-2034 (US$ Million)
Figure 18. Global Dog Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 19. Global Dog Vaccines Sales Quantity 2018-2034 (K Doses)
Figure 20. Global Dog Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 21. Global Dog Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Dog Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 23. North America Dog Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Dog Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 25. Europe Dog Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Dog Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 27. China Dog Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Dog Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 29. APAC Dog Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Dog Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 31. Middle East, Africa and Latin America Dog Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Dog Vaccines Sales Quantity in 2022
Figure 33. The Top 10 and Top 5 Players Market Share by Dog Vaccines Revenue in 2022
Figure 34. Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 37. Global Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 39. North America Dog Vaccines Revenue Market Share by Company in 2022
Figure 40. North America Dog Vaccines Sales Quantity Market Share by Company in 2022
Figure 41. North America Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 43. North America Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 45. North America Dog Vaccines Revenue Share by Country (2018-2034)
Figure 46. North America Dog Vaccines Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Dog Vaccines Sales Quantity Market Share by Company in 2022
Figure 50. Europe Dog Vaccines Revenue Market Share by Company in 2022
Figure 51. Europe Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 53. Europe Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 55. Europe Dog Vaccines Revenue Share by Country (2018-2034)
Figure 56. Europe Dog Vaccines Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. France Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 62. China Dog Vaccines Sales Quantity Market Share by Company in 2022
Figure 63. China Dog Vaccines Revenue Market Share by Company in 2022
Figure 64. China Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 66. China Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 68. APAC Dog Vaccines Sales Quantity Market Share by Company in 2022
Figure 69. APAC Dog Vaccines Revenue Market Share by Company in 2022
Figure 70. APAC Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 72. APAC Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 74. APAC Dog Vaccines Revenue Share by Region (2018-2034)
Figure 75. APAC Dog Vaccines Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. India Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Dog Vaccines Sales Quantity Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Dog Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Dog Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Dog Vaccines Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Dog Vaccines Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Dog Vaccines Revenue Share by Country (2018-2034)
Figure 89. Brazil Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Dog Vaccines Revenue (2018-2034) & (US$ Million)
Figure 94. Dog Vaccines Value Chain
Figure 95. Dog Vaccines Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed